Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis

Journal of Neuroimmunology

Volumn 93, Issue 1-2, 1999, Pages 108-121

  Karachunski, Peter I ^a   Ostlie, Norma S ^a   Okita, David K ^b   Garman, Richard ^c   Conti Fine, Bianca M ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c 610 Lincoln Street   (United States)

Author keywords

Acetylcholine receptor; Autoimmunity; Experimental myasthenia gravis; Subcutaneous tolerance; Th2 cells

Indexed keywords

CD4 ANTIGEN; CHOLINERGIC RECEPTOR; EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; HELPER CELL; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; AUTOANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DISEASE MODELS, ANIMAL; EPITOPES; IMMUNE TOLERANCE; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED STRAINS; MYASTHENIA GRAVIS; PEPTIDE FRAGMENTS; RECEPTORS, CHOLINERGIC; SOLUBILITY; TH2 CELLS; TORPEDO;

EID: 0032917213     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00208-2     Document Type: Article

References (41)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T-lymphocytes. Nature. 383:1996;787-793.
2. Al-Sabbagh A., Nelson P., Akselband Y., Sobel R., Weiner H. Antigen-driven peripheral immune tolerance - suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen. Cell Immunol. 171:1996;111-119.
3. Bellone M., Ostlie N., Lei S., Conti-Tronconi B. Experimental myasthenia gravis in congenic mice: sequence mapping and H-2 restriction of T-helper epitopes on the a subunits of Torpedo californica and murine acetylcholine receptors. Eur. J. Immunol. 21:1991;2010-2303.
4. + cells sensitized to nicotinic acetylcholine receptor. J. Immunol. 147:1991;1484-1491.
5. + cells. J. Immunol. 151:1993;1025-1038.
6. Bellone M., Karachunski P., Ostlie N., Lei S., Conti-Tronconi B.M. Clustering of B- and T-epitopes within short sequence regions of the nicotinic acetylcholine receptor. Scand. J. Immunol. 41:1995;135-140.
7. Briner T.J., Kuo M.C., Keating K.M., Rogers B.L., Greenstein J.L. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc. Nat. Acad. Sci. USA. 90:1993;7608-7612.
8. Burstein H.J., Shea C.M., Abbas A.K. Aqueous antigens induce in vivo tolerance selectively in IL-2 and IFN-gamma-producing (Th1) cells. J. Immunol. 148:1992;3687-3691.
9. Chen Y., Inobe J., Marks R., Gonnella P., Kuchroo V., Weiner H. Peripheral deletion of antigen-reactive T-cells in oral tolerance. Nature. 376:1995;177-180.
10. Chen Y., Inobe J., Kuchroo V., Baron J., Janeway C.J., Weiner H. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA. 93:1996;388-391.
11. + T-cell responses: the alternative approach. Annu. Rev. Immunol. 15:1997;297-322.
12. Conti-Fine B.M., McLane K.E., Lei S. Antibodies as a tool to study the structure of membrane proteins: the case of the nicotinic receptor. Annu. Rev. Biophys. Biomol. Struct. 25:1996;197-229.
13. Conti-Fine, B.M., Protti, M.P., Bellone, M., Howard Jr., J.F., 1997. Myasthenia Gravis: The Immunobiology of an Autoimmune Disease. R.G. Landes, Austin, p. 230.
14. de Wit D., Van Mechelen M., Reylandt M., Figuerido A.C., Abramovitz D., Goldman M., Bazin H., Urbain J., Leo O. The injection of degradated gamma globulins in adult mice induces antigen-specific unresponsiveness of T-helper type 1 but not type 2 lymphocytes. J. Exp. Med. 175:1992;9-14.
15. Ding L., Shevach E.M. IL-10 inhibits mitogen-induced T-cell proliferation by selectively inhibiting macrophage co-stimulatory function. J. Immunol. 148:1992;3133-3139.
16. Enk A.H., Angeloni V.L., Udey M.C., Katz S.I. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J. Immunol. 151:1993;2390-2398.
17. Genain C.P., Abel K., Belmar N., Villinger F., Rosenberg D.P., Linington C., Raine C.S., Hauser S.L. Late complications of immune deviation therapy in a non-human primate. Science. 274:1996;2054-2057.
18. Gregerson D.S., Obritsch W., Donoso L. Oral tolerance in experimental autoimmune uveoretinitis: distinct mechanisms of resistance are induced by low dose vs. high dose feeding protocols. J. Immunol. 151:1993;5751-5761.
19. + T-cells. J. Exp. Med. 184:1996;1-8.
20. Hohlfeld R. Biotechnological agents for the immunotherapy of multiple sclerosis: principles, problems and perspectives. Brain. 120:1997;865-916.
21. Husby S., Mestecky J., Moldoveanu Z., Holland S., Elson C. Oral tolerance in humans: T-cell but not B-cell tolerance after antigen feeding. J. Immunol. 152:1994;4663-4670.
22. Infante A., Thompson P., Krolik K., Wall K. Determinant selection in murine experimental autoimmune myasthenia gravis: effect of the bm12 mutation on T-cell recognition of acetylcholine receptor epitopes. J. Immunol. 146:1991;2977-2982.
23. bm12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice. Scand. J. Immunol. 42:1995;215-225.
24. Karachunski P.I., Ostlie N.S., Okita D.K., Conti-Fine B.M. Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T-epitope sequences. J. Clin. Invest. 100:1997;3027-3035.
25. Liblau R., Tisch R., Bercovici N., McDevitt H.O. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases. Immunol. Today. 18:1997;599-604.
26. Liu L., MacPherson G.G. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T-cells in vivo. J. Exp. Med. 177:1993;1299-1307.
27. Ma C., Zhang G., Xiao B., Link H. Cellular mRNA of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG). Clin. Exp. Immunol. 104:1996;509-516.
28. Macatonia S.E., Doherty T.M., Knight S.C., O'Garra A. Differential effect of IL-10 on dendritic cell-induced T-cell proliferation and IFN-gamma production. J. Immunol. 150:1993;3755-3765.
29. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
30. Metzler B., Wraith D.C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5:1993;1159-1165.
31. Miller S.D., Karpus W.J. The immunopathogenesis and regulation of T-cell mediated demyelinating diseases. Immunol. Today. 8:1994;356-361.
32. Neutra M., Pringult E., Kraehenbuhl J. Antigen sampling across epithelial barriers and induction of mucosal immune response. Annu. Rev. Immunol. 14:1996;275-300.
33. Norman P.S., Ohman J.L. Jr., Long A.A., Gefter P.S., Shaked Z., Wood R.A., Eggleston P.A., Hafner K.B., Rao P., Lichtenstein L.M., Jones N.H., Nicodemus C.F. Treatment of cat allergy with T-cell reactive peptides. Am. J. Res. Crit. Med. 154:1996;1623-1628.
34. Nossal G.J. Choices following antigen entry: antibody formation or immunologic tolerance? Annu. Rev. Immunol. 13:1995;1-27.
35. O'Garra A. Cytokines induce the development of functionally heterogenous T-helper cell subsets. Immunity. 8:1998;275-283.
36. Tian J., Atkinson M.A., Clare-Salzer M., Hershenfeld A., Forsthuber T., Lehmann P.V., Kaufman D.L. Nasal administration of glutamate decarboxylase (GAD65) peptide induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1996;1561-1567.
37. Tian J., Lehmann P.V., Kaufman D.L. Determinant spreading of T-helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186:1997;2039-2043.
38. Wang Z.-Y., Okita D., Howard J. Jr., Conti-Fine B.M. TH1 epitope repertoire on the α subunit of human muscle acetylcholine receptor in myasthenia gravis. Neurology. 48:1997;1643-1653.
39. Wang Z.-Y., Okita D., Howard J. Jr., Conti-Fine B.M. T-cell recognition of the muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology. 50:1998;1045-1054.
40. Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R.B., Trenthan D.E., Hafler D.A. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:1994;809-837.
41. Wu B., Deng C., Goluszko E., Christadoss P. Tolerance to a dominant T-cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis. J. Immunol. 159:1997;3016-3023.